In comparison to non-GCK-MODY patients, those with MODYX displayed increased 2-hour postload blood glucose levels (P = .01), △2-hour glucose (P = .019), a greater susceptibility to DK/DKA (P = .003), and more frequent usage of insulin injections (P = .027). The gene discussed is INS; the disease is MODY.